Gastrointestinal Cancer News

The FDA revised an existing indication of pembrolizumab for the first-line treatment of certain patients with gastric or gastroesophageal junction adenocarcinoma.

The FDA approved fruquintinib for certain adults with previously treated metastatic colorectal cancer.

Active cancer during transcatheter aortic valve replacement did not increase in-hospital mortality, but certain cancer types were tied to elevated rehospitalization and major bleeding risk in the following months, researchers reported.

Black individuals with early-onset colorectal cancer received worse and less timely care compared with white patients, according to results of a national hospital-based study.

Two different treatment regimens showed efficacy among patients with gastroesophageal cancers, according to study results presented during an ASCO Plenary Series session.

Patients with acute-on-chronic liver failure and recompensated cirrhosis had less severe disease, lower incidence of respiratory failure and better prognosis at 1 year vs. those with decompensated cirrhosis, researchers reported.

VANCOUVER, British Columbia — Results from a systematic review and network meta-analysis showed 10 interventions, including dual observation, iScan and G-EYE, improved adenoma detection rate during screening-related colonoscopy.

VANCOUVER, British Columbia — A digital risk assessment tool and genetic testing program can be helpful in identifying patients with high-risk cancer susceptibility syndromes, according to a presenter at the ACG Annual Scientific Meeting.

Researchers at The University of Texas MD Anderson Cancer Center have made improvements to hospital care pathways that reduced opioid use by 50% after pancreatic cancer surgery.

VANCOUVER, British Columbia — Mechanical-enhanced colonoscopy outperformed standard colonoscopy in polyp detection rate and estimated adenoma detection rate for colorectal cancer screening, according to a presenter here.